Table 1.
Characteristics of patients with RA patients and Healthy controls (HCs)
| Clinical variables | RA patients (n = 61) | HCs (n = 40) |
|---|---|---|
| Sex, female/male (n) | 51/10 | 37/3 |
| Age, years mean ± SEM | 43.15 ± 15.46 | 44.68 ± 13.39 |
| Disease duration, months | 10 (4–36) | |
| ESR, mm/h | 27 (16–41.5) | |
| CRP, mg/l | 6.95 (3.20–17.4) | |
| DAS28-ESR | 4.39 (2.83–5.58) | |
| DAS28-CRP | 3.64 (3.01–4.92) | |
| Tender joint count | 6 (3.5–15) | |
| Swollen joint count | 7.5 (2.75–17.5) | |
| Anti-CCP, IU/ml | 21.9 (0.63–266.9) | |
| Anti-CCP, positivity | 50/61 (82.0%) | |
| RF, IU/ml | 27.5 (12.0–160.8) | |
| RF, positivity | 43/61 (70.5%) |
All the data were demonstrated as median [IQR, 25th–75th percentile]
RA, rheumatoid arthritis; DAS28-ESR, Disease Activity Score in 28 joints using the erythrocyte sedimentation rate; CRP, C-reactive protein; RF, rheumatoid factor; anti-CCP, anti-cyclic citrullinated peptide